Orally Disintegrating Tablet (ODT) Market Analysis, Size, Current Scenario and Future Prospects
For instance, in February 2022, Dr Reddy's Laboratories Ltd. along with its subsidiaries announced the launch of Lansoprazole DR Orally Disintegrating Tablets. These tablets are a therapeutic equivalent generic version of Prevacid SoluTab delayed-release orally disintegrating tablets, 15 mg and 30 mg, which is approved by the US FDA. Additionally, in July 2021, SPI Pharma launched UltraBurst an orally disintegrating tablet (ODT). Ultrabrust is an innovative excipient platform for flash ODTs, which disintegrate in under ten seconds. Furthermore, in December 2021, Edenbridge Pharmaceuticals, LLC announced the approval of its New Drug Application (NDA) for DARTISLA ODT (glycopyrrolate) orally disintegrating tablets from the US FDA. DARTISLA ODT is an orally disintegrating tablet available in 1.7 mg for the treatment of peptic ulcers in adults.
Some major players in the market include Teva Pharmaceutical Industries Ltd., Merck KGaA, and Mylan N.V., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2021, Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the US. Rimegepant is commercialized as Nurtec ODT in the US and is used for the treatment of episodic migraine in adults.
To Request a Sample of our Report on Orally Disintegrating Tablet (ODT) Market: https://www.omrglobal.com/request-sample/orally-disintegrating-tablet-odt-market
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2022-2030
• Segment Covered-
· By Drug Class
· By Disease Indication
· By Distribution Channel
• Regions Covered-
· North America
· Rest of the World
• Competitive Landscape- Teva Pharmaceutical Industries Ltd., Merck KGaA, and Mylan N.V., among others.
A full Report Orally Disintegrating Tablet (ODT) Market is Available @ https://www.omrglobal.com/industry-reports/orally-disintegrating-tablet-odt-market
Orally Disintegrating Tablet (ODT) Market Report by Segment
By Drug Class
• CNS Stimulants
• Anti-Parkinsonian Drugs
• Anti-Allergy Drugs
By Disease Indication
• CNS Diseases
• GI Diseases
• CVS Disorders
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
Orally Disintegrating Tablet (ODT) Market Report by Region
· United States
· Rest of Europe
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orally Disintegrating Tablet (ODT) Market Analysis, Size, Current Scenario and Future Prospects here
News-ID: 3229398 • Views: 302
More Releases from Orion Market Research
Veterinary Vaccines Market Trends, Segmentation, Growth, Analysis and Forecast 2 …
The global veterinary vaccines market is anticipated to grow at a CAGR of 9.2% during the forecast period. The growing awareness regarding animal vaccination through government campaigns is driving the growth of the market. For instance, in July 2022, the Government of Liberia in collaboration with its One Health platform partners and the division of Veterinary Services at the Ministry of Agriculture (MoA), launched a 13 - day national emergency
Alginate Dressing Market Trends, Segmentation, Growth, Analysis and Forecast 202 …
The global alginate dressing market is anticipated to grow at a considerable CAGR of 4.9% during the forecast period. The rising incidence of acute & chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical & traumatic wounds, burns, and others is boosting the global alginate dressing market. As alginate dressings are widely used in the treatment of exuding wounds and due to its antibacterial activity, alginate
Pediatric Neuroblastoma Treatment Market Trends, Segmentation, Growth, Analysis …
The global pediatric neuroblastoma treatment market is anticipated to grow at a CAGR of 10.3% during the forecast period. Product approvals and clinical trials have paved the way for the introduction of new therapeutic options, addressing the complex nature of neuroblastoma and improving treatment outcomes. Through the process of product approvals, regulatory authorities such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) evaluate the
Orthopedic Power Tools Market Share, Trends, Future Outlook, Analysis and Foreca …
The global orthopedic power tools market is anticipated to grow at a considerable CAGR of 4.1% during the forecast period. The launch of orthopedic clinics propels the demand for the orthopedic power tools market. With increased patient volume and adoption of advanced surgical techniques, there is a growing requirement for power tools in orthopedic procedures. Orthopedic clinics uses advanced surgical techniques and technologies that require orthopedic power tools to enhance
More Releases for ODT
Orally Disintegrating Tablet (ODT) Market Share 2021 Growth Challenges, Opportun …
The global orally disintegrating tablet (ODT) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). According to the US Food and Drug Administration (FDA), ODT’s are a solid dosage form that contains a medicinal substance or active ingredient which rapidly disintegrates when placed upon the tongue within a second. The major factor for the growth of the global orally disintegrating tablet (ODT) market during the
Orally Dissolving Tablets (ODT) Excipient Market global outlook and forecast 202 …
The Global Orally Dissolving Tablets (ODT) Excipient Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Orally Dissolving Tablets (ODT) Excipient makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and
Investigation announced for Long-Term Investors in shares of Odonate Therapeutic …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Odonate Therapeutics, Inc.. Investors who are current long term investors in Odonate Therapeutics, Inc. (NASDAQ: ODT) shares, have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: ODT stocks follows a lawsuit filed against Odonate
Deadline on Nov. 16th coming up in Lawsuit for Investors in Odonate Therapeutics …
The Shareholders Foundation announced that a deadline is coming up on November 16, 2020 in the lawsuit filed for certain investors of Odonate Therapeutics, Inc. (NASDAQ: ODT) over alleged securities laws violations by Odonate Therapeutics, Inc. Investors who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT) have certain options and there are strict and short deadlines running. Deadline: November 16, 2020. NASDAQ: ODT stockholders should contact the Shareholders Foundation at
Lawsuit filed for Investors in shares of Odonate Therapeutics, Inc. (NASDAQ: ODT …
An investor, who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT), filed a lawsuit over alleged Securities Laws violations by Odonate Therapeutics, Inc. Investors who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 16, 2020. NASDAQ: ODT investors should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554. San Diego, CA based Odonate Therapeutics,
Trending: Orally Disintegrating Tablet (ODT) Market By End-User Segments Forecas …
LOS ANGELES, United States: QY Research as of late produced a research report titled, “Global Orally Disintegrating Tablet (ODT) Market Research Report 2020". The research report speak about the potential development openings that exist in the worldwide market. The report is broken down on the basis of research procedures procured from historical and forecast information. The global Orally Disintegrating Tablet (ODT) market is relied upon to develop generously and flourish